Plain-English translation Regenerative Medicine
PMID 34211557
DOI 10.1155/2021/9921015
Royal College British Orthopaedic AO Trauma Churchill Limb Recon Specialist Reg.

Heidari N, Borg TM, Olgiati S, Slevin M, Danovi A, Fish B, et al.. Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two Years. Stem Cells International, 2021.

Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two Years

Heidari N, Borg TM, Olgiati S, Slevin M, Danovi A, Fish B, et al.. — Heidari N: First Author

This is a plain-English translation of the academic paper above, prepared for patients, referring clinicians, and other non-specialist readers. It preserves the structure of the original paper while removing technical jargon. For the full clinical paper, follow the PubMed or DOI links.

Background

Whether a single injection of the patient’s own fat tissue (MFAT) into a worn knee joint could relieve pain and improve quality of life enough to delay or avoid the need for a total knee replacement — particularly for patients who would normally be heading for surgery.

Rationale

Knee replacement works well, but access to it is rationed by waiting lists, by the rules in different healthcare systems, and during periods like the COVID pandemic, when planned operations were paused. Patients in pain in the meantime need alternatives that genuinely help — not just placebo effects.

Results

220 patients with severe knee arthritis (the worst grades on x-ray) received one MFAT injection. Two years later, even in the group whose pre-treatment scores had marked them as suitable for a knee replacement, quality-of-life scores had improved significantly. The improvement was strong enough to suggest that MFAT can postpone the need for surgery in many of these patients.

Implications

For people with advanced knee arthritis facing a long wait for knee replacement, an MFAT injection appears to be a low-risk option that may help in the meantime — and may genuinely delay the need for surgery in some patients. The study is observational, not a randomised trial, so the result is best read as a strong signal rather than a definitive answer.

Source: Heidari N, Borg TM, Olgiati S, Slevin M, Danovi A, Fish B, et al.. Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two Years. Stem Cells International 2021;2021:9921015. doi:10.1155/2021/9921015

Read full open-access paper (PDF) → Read original on PubMed → ← Back to research library